Dr. Fraser Murray PhD MBAChief Scientific Officer

    Dr Murray brings more than 20 years’ of drug discovery and early development experience across a range of therapeutic areas, including neurodegeneration, psychiatry, inflammation and dermatology.

    He has held leadership roles at Shire, AstraZeneca and Merck. Prior to co-founding Polleo Pharma and raising investment to fund the portfolio, Dr Murray was Senior Director and Head of Discovery Biology for Shire Speciality Pharmaceuticals, focused on CNS and GI disorders.

    Dr Murray holds a PhD from The School of Pharmacy UCL, a BSc from the University of Strathclyde and an MBA from Alliance Manchester Business School.

    Contact Us

    Want to get in touch? Send us an email.

    Not readable? Change text. captcha txt